These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Alpha-melanocyte-stimulating hormone blocks invasion of reconstituted basement membrane (Matrigel) by murine B16 melanoma cells. Murata J; Ayukawa K; Ogasawara M; Fujii H; Saiki I Invasion Metastasis; 1997; 17(2):82-93. PubMed ID: 9561027 [TBL] [Abstract][Full Text] [Related]
3. Effects of histone deacetylase inhibitors on estradiol-induced proliferation and hyperplasia formation in the mouse uterus. Gunin AG; Kapitova IN; Suslonova NV J Endocrinol; 2005 Jun; 185(3):539-49. PubMed ID: 15930180 [TBL] [Abstract][Full Text] [Related]
4. Down-regulation of matrix-invasive potential of human liver cancer cells by type I interferon and a histone deacetylase inhibitor sodium butyrate. Kaneko F; Saito H; Saito Y; Wakabayashi K; Nakamoto N; Tada S; Suzuki H; Tsunematsu S; Kumagai N; Ishii H Int J Oncol; 2004 Apr; 24(4):837-45. PubMed ID: 15010820 [TBL] [Abstract][Full Text] [Related]
5. Cyclic hydroxamic-acid-containing peptide 31, a potent synthetic histone deacetylase inhibitor with antitumor activity. Komatsu Y; Tomizaki KY; Tsukamoto M; Kato T; Nishino N; Sato S; Yamori T; Tsuruo T; Furumai R; Yoshida M; Horinouchi S; Hayashi H Cancer Res; 2001 Jun; 61(11):4459-66. PubMed ID: 11389076 [TBL] [Abstract][Full Text] [Related]
6. Autocrine motility factor signals integrin-mediated metastatic melanoma cell adhesion and invasion. Timar J; Trikha M; Szekeres K; Bazaz R; Tovari J; Silletti S; Raz A; Honn KV Cancer Res; 1996 Apr; 56(8):1902-8. PubMed ID: 8620512 [TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitors up-regulate the expression of tight junction proteins. Bordin M; D'Atri F; Guillemot L; Citi S Mol Cancer Res; 2004 Dec; 2(12):692-701. PubMed ID: 15634758 [TBL] [Abstract][Full Text] [Related]
8. Suppression of caspase-11 expression by histone deacetylase inhibitors. Heo H; Yoo L; Shin KS; Kang SJ Biochem Biophys Res Commun; 2009 Jan; 378(1):79-83. PubMed ID: 19013432 [TBL] [Abstract][Full Text] [Related]
9. Impairment of the metastatic activity of melanoma cells by transglutaminase-catalyzed incorporation of polyamines into laminin and Matrigel. Lentini A; Provenzano B; Caraglia M; Shevchenko A; Abbruzzese A; Beninati S Amino Acids; 2008 Feb; 34(2):251-6. PubMed ID: 17356804 [TBL] [Abstract][Full Text] [Related]
10. Regulation of adipocyte differentiation by histone deacetylase inhibitors. Kim SN; Choi HY; Kim YK Arch Pharm Res; 2009 Apr; 32(4):535-41. PubMed ID: 19407971 [TBL] [Abstract][Full Text] [Related]
11. Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate. Sekhavat A; Sun JM; Davie JR Biochem Cell Biol; 2007 Dec; 85(6):751-8. PubMed ID: 18059533 [TBL] [Abstract][Full Text] [Related]
12. [4-acetamidophenyl retinoate (4-APR) inhibits reconstituted basement membrane invasion by tumor cells and its mechanism]. Shi B; Han R Zhonghua Zhong Liu Za Zhi; 1997 May; 19(3):196-9. PubMed ID: 10920895 [TBL] [Abstract][Full Text] [Related]
13. A new in vitro assay for quantitating tumor cell invasion. Repesh LA Invasion Metastasis; 1989; 9(3):192-208. PubMed ID: 2722434 [TBL] [Abstract][Full Text] [Related]
14. Telomerase expression and cell proliferation in ovarian cancer cells induced by histone deacetylase inhibitors. Zhu K; Qu D; Sakamoto T; Fukasawa I; Hayashi M; Inaba N Arch Gynecol Obstet; 2008 Jan; 277(1):15-9. PubMed ID: 17680259 [TBL] [Abstract][Full Text] [Related]
15. Amplification of recombinant adenoviral transgene products occurs by inhibition of histone deacetylase. Dion LD; Goldsmith KT; Tang DC; Engler JA; Yoshida M; Garver RI Virology; 1997 May; 231(2):201-9. PubMed ID: 9168882 [TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitors promote neurosteroid-mediated cell differentiation and enhance serotonin-stimulated brain-derived neurotrophic factor gene expression in rat C6 glioma cells. Morita K; Gotohda T; Arimochi H; Lee MS; Her S J Neurosci Res; 2009 Aug; 87(11):2608-14. PubMed ID: 19360904 [TBL] [Abstract][Full Text] [Related]
17. [Anti-invasive and anti-metastatic effect of ampelopsin on melanoma]. Zheng HQ; Liu DY Ai Zheng; 2003 Apr; 22(4):363-7. PubMed ID: 12703989 [TBL] [Abstract][Full Text] [Related]
18. Decreased syndecan-2 expression correlates with trichostatin-A induced-morphological changes and reduced tumorigenic activity in colon carcinoma cells. Kim Y; Park H; Lim Y; Han I; Kwon HJ; Woods A; Oh ES Oncogene; 2003 Feb; 22(6):826-30. PubMed ID: 12584561 [TBL] [Abstract][Full Text] [Related]
19. [Effects of ampelopsin on invasion and metastasis of B16 mouse melanoma in vivo and in vitro]. Liu DY; Zheng HQ; Luo GQ Zhongguo Zhong Yao Za Zhi; 2003 Oct; 28(10):957-61. PubMed ID: 15620188 [TBL] [Abstract][Full Text] [Related]
20. Mel-CAM-specific genetic suppressor elements inhibit melanoma growth and invasion through loss of gap junctional communication. Satyamoorthy K; Muyrers J; Meier F; Patel D; Herlyn M Oncogene; 2001 Aug; 20(34):4676-84. PubMed ID: 11498790 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]